中华内分泌代谢杂志
中華內分泌代謝雜誌
중화내분비대사잡지
CHINESE JOURNAL OF ENDOCRINOLOGY AND METABOLISM
2014年
12期
1140-1143
,共4页
老年人%亚临床甲状腺功能减退症%诊断%治疗
老年人%亞臨床甲狀腺功能減退癥%診斷%治療
노년인%아림상갑상선공능감퇴증%진단%치료
Elderly%Subclinical hypothyroidism%Diagnosis%Treatment
亚临床甲状腺功能减退(甲减)是一种实验室诊断,定义为血清TSH水平高于正常参考范围上限,FT4水平正常.甲状腺功能改变与年龄增长相关,现有的研究均显示随着年龄的增长,亚临床甲减患病率增加,女性更为明显.但是随着年龄增长,血清TSH水平升高,所以有研究建议老年人血清TSH的参考范围应放宽.正因如此,老年人亚临床甲减治疗时机及治疗目标争论最多.目前建议老年人亚临床甲减,当TSH≥10 mIU/L时考虑左旋甲状腺素治疗;当TSH介于正常参考值上限和10 mIU/L之间,结合患者症状、是否有心血管疾病史以及患病危险因素决定是否治疗.治疗的目标根据患者的年龄和心脏等情况个体化制定.
亞臨床甲狀腺功能減退(甲減)是一種實驗室診斷,定義為血清TSH水平高于正常參攷範圍上限,FT4水平正常.甲狀腺功能改變與年齡增長相關,現有的研究均顯示隨著年齡的增長,亞臨床甲減患病率增加,女性更為明顯.但是隨著年齡增長,血清TSH水平升高,所以有研究建議老年人血清TSH的參攷範圍應放寬.正因如此,老年人亞臨床甲減治療時機及治療目標爭論最多.目前建議老年人亞臨床甲減,噹TSH≥10 mIU/L時攷慮左鏇甲狀腺素治療;噹TSH介于正常參攷值上限和10 mIU/L之間,結閤患者癥狀、是否有心血管疾病史以及患病危險因素決定是否治療.治療的目標根據患者的年齡和心髒等情況箇體化製定.
아림상갑상선공능감퇴(갑감)시일충실험실진단,정의위혈청TSH수평고우정상삼고범위상한,FT4수평정상.갑상선공능개변여년령증장상관,현유적연구균현시수착년령적증장,아림상갑감환병솔증가,녀성경위명현.단시수착년령증장,혈청TSH수평승고,소이유연구건의노년인혈청TSH적삼고범위응방관.정인여차,노년인아림상갑감치료시궤급치료목표쟁론최다.목전건의노년인아림상갑감,당TSH≥10 mIU/L시고필좌선갑상선소치료;당TSH개우정상삼고치상한화10 mIU/L지간,결합환자증상、시부유심혈관질병사이급환병위험인소결정시부치료.치료적목표근거환자적년령화심장등정황개체화제정.
Based on laboratory tests,subclinical hypothyroidism is diagnosed and defined as an elevated serum TSH concentration with FT4 within reference range.Alterations in thyroid function are associated with aging.All available studies show that prevalence of subclinical hypothyroidism increases with aging,especially in women.However,some studies advise that serum TSH reference range for older people should be modified,because serum TSH elevates with aging.Therefore,when to and how to treat subclinical hypothyroidism in the elderly has been debating fiercely.At present,levothyroxine sodium treatment is generally recommended when TSH is raised more than 10 mIU/L.When TSH level is between the upper limit of the reference range and 10 mIU/L,treatment should depend on symptoms,history and risk factors of cardiovascular disease.Therapeutic objective should be individualized,depending on age,cardiac function,and other conditions.